unknown
Stage
About
Akiram Therapeutics develops targeted radioimmunotherapy treatments using radioactive molecules to precisely diagnose and treat solid tumors, focusing on metastatic cancers with a therapeutic approach that minimizes damage to healthy tissue.
Explore Akiram Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.